Sickle cell disease is an inherited blood disorder that affects about one in 12 African Americans. During National Minority Health Month, learn more about NCATS’ work on a potential treatment.
NCATS researchers develop new technologies that can be transferred — through collaborations and licenses — to others for further research, development and commercialization.
NCATS is seeking innovative and dedicated professionals to join its dynamic staff. Learn more about our current job opportunities.
Collaborators from NCATS and NCI published a study demonstrating the system’s power to find drug combinations to treat a type of blood cancer.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Regulatory agencies face record applications for rare disease therapies.
Connecting researchers and industry to find new treatments for patients.
- NIH Policy for Managing Conflict of Interest in the Peer Review of Concepts and Proposals for Research and Development Contract Projects
- Adjustments to May 25-28, 2014 Grant Application Due Dates
- NIH Extramural Grant Systems Upgrade for Unicode Compatibility Means Memorial Day Weekend Downtime
- More Funding & Notices...
- Wisconsin Research Shows Green Space Keeps You from Feeling Blue • University of Wisconsin School of Medicine and Public Health
- IU Bloomington Faculty Awarded Indiana Clinical and Translational Sciences Grants • Indiana University
- UC Led Research Finds Chips with Olestra Cause Body Toxins to Dip • University of Cincinnati
- More News & Events...